Pfizer Recalling Some Blood Pressure Drug Products With ‘Above Acceptable’ Levels of Cancer-Causing Impurity

Pfizer Recalling Some Blood Pressure Drug Products With ‘Above Acceptable’ Levels of Cancer-Causing Impurity
The Pfizer Inc. logo is seen at its headquarters in New York, on Dec. 9, 2020. Angela Weiss/AFP via Getty Images
Katabella Roberts
Updated:

Pfizer says that it’s voluntarily recalling some of its blood pressure drug products and two authorized cheaper generic versions of the drug because of elevated levels of a potentially cancer-causing impurity.

The pharmaceutical giant stated on March 21 that it’s recalling six lots of Accuretic (quinapril HCl/hydrochlorothiazide) tablets, one lot of quinapril and hydrochlorothiazide tablets, and four lots of quinapril HCl/ hydrochlorothiazide tablets that are used to treat the symptoms of high blood pressure.
Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics